APP-FUBINACA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
APP-FUBINACA
APP-FUBINACA.png
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
Chemical and physical data
Formula C24H21FN4O2
Molar mass 416.5 g/mol
3D model (JSmol)

APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1] Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.[2] It contains a phenylalanine amino acid residue in its structure.

Legality[edit]

Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.[3]

See also[edit]

References[edit]

  1. ^ "APP-FUBINACA". Cayman Chemical. Retrieved 15 July 2015. 
  2. ^ Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
  3. ^ "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 16 July 2015.